Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Transgene - Filing #881725

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Foreign exchange gain (loss) [abstract]
Foreign exchange gain (loss)
12,000 EUR
7,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
39 593 EUR
54 766 EUR
Current assets
62 245 EUR
30 687 EUR
Non-current liabilities
20 040 EUR
21 108 EUR
Current liabilities
14 589 EUR
13 629 EUR
Revenue
9 993 EUR
2 981 EUR
Profit (loss)
19 536 EUR
 -  EUR
 -  EUR
 -  EUR
 -  EUR
19 536 EUR
19 536 EUR
 -  EUR
 -  EUR
 -  EUR
17 231 EUR
 -  EUR
17 231 EUR
17 231 EUR
 -  EUR
 -  EUR
Other comprehensive income
 -  EUR
61,000 EUR
 -  EUR
 -  EUR
 -  EUR
61,000 EUR
372,000 EUR
 -  EUR
 -  EUR
 -  EUR
7,000 EUR
 -  EUR
70,000 EUR
 -  EUR
70,000 EUR
 -  EUR
Comprehensive income
19 536 EUR
372,000 EUR
 -  EUR
 -  EUR
 -  EUR
19 908 EUR
19 908 EUR
 -  EUR
 -  EUR
 -  EUR
17 224 EUR
 -  EUR
17 224 EUR
17 231 EUR
7,000 EUR
 -  EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.